Simplex Trading
IPSC icon

Simplex Trading’s Century Therapeutics IPSC Stock Holding History

Simplex Trading’s Portfolio IPSC Stock Details IPSC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.29K Hold
1,900
– – ﹤0.01% 7986
2025
Q4 		$1.89K Buy
+1,900
New +$1.16K ﹤0.01% 7854

Other funds holding IPSC

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

Simplex Trading's IPSC Position: Q1 2026 in Review

Simplex Trading increased its Century Therapeutics (IPSC) stake by 277% in Q1 2026, buying an estimated $13.9K and bringing the position to 9,028 shares worth $20.4K. The position accounts for ﹤0.01% of the portfolio, ranked #6763.

Simplex Trading first reported a position in IPSC in Q2 2023 and has held it in 6 quarters since. 72 funds tracked by Wall St. Rank hold IPSC as of Q1 2026.

  • Simplex Trading held 9,028 shares of Century Therapeutics worth $20.4K as of Q1 2026.
  • Simplex Trading bought 6,631 Century Therapeutics shares in Q1 2026, an estimated $13.9K.
  • Century Therapeutics made up ﹤0.01% of Simplex Trading's portfolio in Q1 2026, its #6763 holding.
  • Simplex Trading first reported a position in Century Therapeutics in Q2 2023 and has held it in 6 quarters since.
  • 72 funds tracked by Wall St. Rank held Century Therapeutics as of Q1 2026.

Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.